Thermo Fisher Scientific Inc. (TMO) Stock Analysis & Investment Frameworks
Thermo Fisher Scientific Inc. (TMO) stock analysis on Invetso. Review Thermo Fisher Scientific Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Thermo Fisher Scientific Inc. Company Overview
- Exchange: New York Stock Exchange
- Sector: Healthcare
- Industry: Medical - Diagnostics & Research
- Country: US
Thermo Fisher Scientific Inc. Key Financial Metrics
- Market Cap: $246.97B
- Revenue: $44.56B
- P/E Ratio: 36.66
- ROE: 13.31%
- ROIC: 7.54%
- Dividend Yield: 0.28%
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
Thermo Fisher Scientific Inc. Investment Frameworks
Invetso analyzes Thermo Fisher Scientific Inc. (TMO) across the following frameworks:
- Thermo Fisher Scientific Inc. 10Y Growth Potential
- Thermo Fisher Scientific Inc. Scenario Analysis
- Thermo Fisher Scientific Inc. Risks & Opportunities
- Thermo Fisher Scientific Inc. Economic Moat
- Thermo Fisher Scientific Inc. Business Model
- Thermo Fisher Scientific Inc. Management
- Thermo Fisher Scientific Inc. SWOT Analysis
- Thermo Fisher Scientific Inc. Porter's 5 Forces
- Thermo Fisher Scientific Inc. PESTLE Analysis
- Thermo Fisher Scientific Inc. ESG Analysis

